The Chemours Company (CC) Stock Forecast
Data as of Aug 1, 2026Basic Materials · Current price $16.58 (-3.10%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 10, 2026 | Arun Viswanathan | RBC Capital | $26.00 | +56.8% |
| Feb 23, 2026 | Laurence Alexander | Jefferies | $17.00 | +2.5% |
| Feb 23, 2026 | Vincent Andrews | Morgan Stanley | $17.00 | +2.5% |
| Jan 19, 2026 | John McNulty | BMO Capital | $20.00 | +20.6% |
| Nov 10, 2025 | Peter Osterland | Truist Financial | $18.00 | +8.6% |
| Oct 16, 2025 | John Roberts | Mizuho Securities | $18.00 | +8.6% |
| Oct 6, 2025 | Joshua Spector | UBS | $21.00 | +26.7% |
| Sep 23, 2025 | John Roberts | Mizuho Securities | $19.00 | +14.6% |
| May 7, 2025 | Joshua Spector | UBS | $17.00 | +2.5% |
| Apr 15, 2025 | John Roberts | Mizuho Securities | $15.00 | -9.5% |
| Oct 11, 2024 | Arun Viswanathan | RBC Capital | $28.00 | +68.9% |
| Oct 7, 2024 | John McNulty | BMO Capital | $32.00 | +93.0% |
| Aug 6, 2024 | John McNulty | BMO Capital | $30.00 | +80.9% |
| Jun 7, 2024 | John Roberts | Mizuho Securities | $25.00 | +50.8% |
| May 29, 2024 | Rich Hilliker | UBS | $31.00 | +87.0% |
| Apr 9, 2024 | John McNulty | BMO Capital | $34.00 | +105.1% |
| Apr 1, 2024 | Joshua Spector | UBS | $28.00 | +68.9% |
| Apr 1, 2024 | Emily Nassedd Mitsch | CFRA | $18.00 | +8.6% |
| Mar 13, 2024 | Linda Bolton Weiser | D.A. Davidson | $24.00 | +44.8% |
| Dec 1, 2023 | Arun Viswanathan | RBC Capital | $40.00 | +141.3% |
Top Analysts Covering CC
CC vs Sector & Market
| Metric | CC | Basic Materials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.36 | 2.36 | 2.42 |
| Analyst Count | 14 | 7 | 19 |
| Target Upside | +55.3% | +120.0% | +17.1% |
| P/E Ratio | -10.01 | -10.61 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $5.94B | $6.04B | $6.15B | 7 |
| 2027-03-31 | $1.51B | $1.55B | $1.61B | 2 |
| 2027-06-30 | $1.73B | $1.77B | $1.83B | 2 |
| 2027-09-30 | $1.61B | $1.65B | $1.71B | 2 |
| 2027-12-31 | $1.40B | $1.44B | $1.49B | 2 |
| 2028-03-31 | $1.54B | $1.58B | $1.64B | 1 |
| 2028-06-30 | $1.77B | $1.81B | $1.88B | 1 |
| 2028-09-30 | $1.64B | $1.68B | $1.74B | 1 |
| 2028-12-31 | $1.44B | $1.48B | $1.53B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.99 | $1.44 | $1.99 | 5 |
| 2027-03-31 | $0.47 | $0.49 | $0.51 | 2 |
| 2027-06-30 | $0.84 | $0.87 | $0.91 | 2 |
| 2027-09-30 | $0.72 | $0.74 | $0.78 | 2 |
| 2027-12-31 | $0.31 | $0.32 | $0.33 | 2 |
| 2028-03-31 | $0.56 | $0.58 | $0.61 | 3 |
| 2028-06-30 | $0.99 | $1.03 | $1.07 | 3 |
| 2028-09-30 | $0.90 | $0.93 | $0.98 | 3 |
| 2028-12-31 | $0.45 | $0.46 | $0.48 | 3 |
Frequently Asked Questions
What is the analyst consensus for CC?
The consensus among 14 analysts covering The Chemours Company (CC) is Buy with an average price target of $25.75.
What is the highest price target for CC?
The highest price target for CC is $42.00, set by Matthew DeYoe at Bank of America Securities on 2021-05-20.
What is the lowest price target for CC?
The lowest price target for CC is $15.00, set by John Roberts at Mizuho Securities on 2025-04-15.
How many analysts cover CC?
14 analysts have issued ratings for The Chemours Company in the past 12 months.
Is CC a buy or sell right now?
Based on 14 analyst ratings, CC has a consensus rating of Buy (2.36/5) with a +55.3% upside to the consensus target of $25.75.
What are the earnings estimates for CC?
Analysts estimate CC will report EPS of $1.44 for the period ending 2026-12-31, with revenue estimated at $6.04B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.